Biology of atherosclerotic plaques: What we are learning from proteomic analysis

Cardiovascular Research

Volumn 72, Issue 1, 2006, Pages 18-29

  Blanco Colio, Luis Miguel ^a   Martín Ventura, Jose Luis ^b   Vivanco, Fernando ^c   Michel, Jean Baptiste ^b   Meilhac, Olivier ^b   Egido, Jesús ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b INSERM   (France)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Atherosclerosis; Proteomics

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CELL CULTURE; CELL PROLIFERATION; CHEMOTAXIS; CHRONIC INFLAMMATION; HUMAN; MOLECULAR MECHANICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SMOOTH MUSCLE FIBER; TISSUE CULTURE; VASCULAR FIBROSIS;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VESSELS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLASMA; PROTEOMICS; SPECIMEN HANDLING;

EID: 33748320860     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.017     Document Type: Review

References (49)

1. Glass C.K., and Witzum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
2. Tuomisto T.T., Korkeela A., Rutanen J., Viita H., Brasen J.H., Riekkinen M.S., et al. Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array: overexpression of HMG-CoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and interleukin receptors. Arterioscler Thromb Vasc Biol 23 (2003) 2235-2240
3. Stoeckli M., Chaurand P., Hallahan D.E., and Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7 (2001) 493-496
4. Chaurand P., Schwartz S.A., and Caprioli R.M. Assessing protein patterns in disease using imaging mass spectrometry. J Proteome Res 3 (2004) 245-252
5. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161 (2002) 1701-1710
6. Duran M.C., Mas S., Martin-Ventura J.L., Meilhac O., Michel O., Gallego-Delgado J., et al. Proteomic analysis of human vessels: application to the atherosclerotic plaques. Proteomics 3 (2003) 973-978
7. Castagna A., Cecconi D., Sennels L., Rappsilber J., Guerrier L., Fortis F., et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 4 (2005) 1917-1930
8. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 17 (2000) 9390-9395
9. Patton W.F. Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 771 (2002) 3-31
10. Opiteck G.J., Ramírez S.M., Jorgenson J.W., and Moseley III M.A. Comprehensive two-dimensional high-performance liquid chromatography for the isolation of overexpressed proteins and proteome mapping. Anal Biochem 258 (1998) 349-361
11. Manabet T. Capillary electrophoresis of proteins for proteomic studies. Electrophoresis 20 (1999) 3116-3121
12. Lee W.C., and Lee K.H. Applications of affinity chromatography in proteomics. Anal Biochem 324 (2004) 1-10
13. Seibert V., Wiesner A., Buschmann T., and Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol Res Pract 200 (2004) 83-94
14. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
15. Fenyo D. Identifying the proteome: software tools. Curr Opin Biotechnol 11 (2000) 391-395
16. DeSouza L., Diehl G., Rodrigues M.J., Guo J., Romaschin A.D., Colgan T.J., et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 4 (2005) 377-386
17. Brunnel A., Labas V., Mailloux A., Sharma S., Vinh J., Vaubourdolle M., et al. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 3 (2003) 714-723
18. McGregor E., Kempster L., Wait R., Welson S.Y., Gosling M., Dunn M.J., et al. Identification and mapping of human saphenous vein medial smooth muscle proteins by two-dimensional polyacrylamide gel electrophoresis. Proteomics 1 (2001) 1405-1414
19. Dupont A., Corseaux D., Dekeyzer O., Drobecq H., Guihot A.L., Susen S., et al. The proteome and secretome of human arterial smooth muscle cells. Proteomics 5 (2005) 585-596
20. McGregor E., Kempster L., Wait R., Gosling M., Dunn M.J., and Powel J.T. F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress. Mol Cell Proteomics 3 (2004) 115-124
21. Pellieux C., Desgeorges A., Pigeon C.H., Chambaz C., Yin H., Hayoz D., et al. Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem 278 (2003) 29136-29144
22. Patton W.F., Erdjument-Bromage H., Marks A.R., Tempst P., and Taubman M.B. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing. J Biol Chem 270 (1995) 21404-21410
23. Jang W.G., Kim H.S., Park K.G., Park Y.B., Yoon K.H., Han S.W., et al. Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics 4 (2004) 3383-3393
24. Verhoeckx K.C., Bijlsma S., de Groene E.M., Witkamp R.F., van der Greef J., and Rodenburg R.J. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 4 (2004) 1014-1028
25. Gadgil H.S., Pabst K.M., Giorgianni F., Umstot E.S., Desiderio D.M., Beranova-Giorgianni S., et al. Proteome of monocytes primed with lipopolysaccharide: analysis of the abundant proteins. Proteomics 3 (2003) 1767-1780
26. Tyson K.L., Weissberg P.L., and Shanahan C.M. Heterogeneity of gene expression in human atheroma unmasked using cDNA representational difference analysis. Physiol Genomics 9 (2002) 121-130
27. Martinet W., Schrijvers D.M., De Meyer G.R., Thielemans J., Knaapen M.W., Herman A.G., et al. Gene expression profiling of apoptosis-related genes in human atherosclerosis: upregulation of death-associated protein kinase. Arterioscler Thromb Vasc Biol 22 (2002) 2023-2029
28. Faber B.C., Cleutjens K.B., Niessen R.L., Aarts P.L., Boon W., Greenberg A.S., et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 89 (2001) 547-554
29. King J.Y., Ferrara R., Tabibiazar R., Spin J.M., Chen M.M., Kuchinsky A., et al. Pathway analysis of coronary atherosclerosis. Physiol Genomics 23 (2005) 103-118
30. Stastny J., Fosslien E., and Robertson A.L. Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis 60 (1986) 131-139
31. You S.A., Archacki S.R., Angheloiu G., Moravec C.S., Rao S.R., Kinter M., et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics 13 (2003) 25-30
32. Donners M.M.P.C., Verluyten M.J., Bouwman F.G., Mariamn E.C.M., Devreese B., Vanrobaeys F., et al. Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J Pathol 206 (2005) 39-45
33. Martinet W., Schrijvers D.M., De Meyer G.R., Herman A.G., and Kockx M.M. Western array analysis of human atherosclerotic plaques: downregulation of apoptosis-linked gene 2. Cardiovasc Res 60 (2003) 259-267
34. Hilker M., Buerke M., Guckenbiehl M., Schwertz H., Buhler J., Moersig W., et al. Rapamycin reduces neointima formation during vascular injury. Vasa 32 (2003) 10-13
35. Lupu F., Bergonzelli G.E., Heim D.A., Cousin E., Genton C.Y., Bachmann F., et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 13 (1993) 1090-1100
36. Liao D.F., Jin Z.G., Baas A.S., Daum G., Gygi S.P., Aebersold R., et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 275 (2000) 189-196
37. Dupont A., Tokarski C., Dekeyzer O., Guihot A.L., Amouyel P., Rolando C., et al. Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics 4 (2004) 1761-1778
38. Fach E.M., Garulacan L.A., Gao J., Xiao Q., Storm S.M., Dubaquie Y.P., et al. In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics 3 (2004) 1200-1210
39. Vivanco F., Martín-Ventura J.L., Duran M.C., Barderas M.G., Blanco-Colio L.M., Dardé V.M., et al. Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 4 (2005) 1181-1191
40. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., Meilhac O., Leclercq A., Michel J.B., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 110 (2004) 2216-2219
41. Martin-Ventura J.L., Nicolas V., Houard X., Blanco-Colio L.M., Leclercq A., Egido J., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol 26 (2006) 1337-1343
42. Righetti P.G., Castagna A., Antonioli P., and Boschetti E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 26 (2005) 297-319
43. Karlsson H., Leanderson P., Tagesson C., and Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5 (2005) 551-565
44. Karlsson H., Leanderson P., Tagesson C., and Lindahl M. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5 (2005) 1431-1445
45. Khovidhunkit W., Duchateau P.N., Medzihradszky K.F., Moser A.H., Naya-Vigne J., Shigenaga J.K., et al. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 176 (2004) 37-44
46. Mateos-Caceres P.J., Garcia-Mendez A., Lopez Farre A., Macaya C., Nunez A., Gomez J., et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 44 (2004) 1578-1583
47. Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
48. Wang Y. Gene expression-driven diagnostics and pharmacogenomics in cancer. Curr Opin Mol Ther 7 (2005) 246-250
49. Xiao Z., Prieto D., Conrads T.P., Veenstra T.D., and Issaq H.J. Proteomic patterns: their potential for disease diagnosis. Mol Cell Endocrinol 230 (2005) 95-106